Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
0.6680
-0.0530 (-7.35%)
At close: May 13, 2025, 4:00 PM
0.6498
-0.0182 (-2.72%)
Pre-market: May 14, 2025, 8:35 AM EDT
Adicet Bio Employees
Adicet Bio had 152 employees as of December 31, 2024. The number of employees increased by 9 or 6.29% compared to the previous year.
Employees
152
Change (1Y)
9
Growth (1Y)
6.29%
Revenue / Employee
n/a
Profits / Employee
-$771,842
Market Cap
55.25M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 152 | 9 | 6.29% |
Dec 31, 2023 | 143 | 11 | 8.33% |
Dec 31, 2022 | 132 | 46 | 53.49% |
Dec 31, 2021 | 86 | 4 | 4.88% |
Dec 31, 2020 | 82 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ACET News
- 7 days ago - Adicet Bio Reports First Quarter 2025 Financial Results and Provides Business Updates - Business Wire
- 13 days ago - Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 14 days ago - Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference - Business Wire
- 15 days ago - Adicet Bio Announces Oral Presentation Highlighting Preclinical ADI-270 Data at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting - Business Wire
- 27 days ago - Adicet Bio Appoints Michael Grissinger to the Board of Directors - Business Wire
- 6 weeks ago - Adicet Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 6 weeks ago - Adicet Bio to Participate in 2025 Canaccord Genuity Horizons in Oncology Virtual Conference - Business Wire
- 2 months ago - Adicet Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Company Progress - Business Wire